| Model Number |
BB811 |
| Medical Device Problem Code |
Fluid/Blood Leak (1250)
|
| Health Effect - Clinical Code |
Hemorrhage/Blood Loss/Bleeding (1888)
|
| Date of Event |
04/01/2026
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
Medtronic received information that during use of a fusion hollow fiber oxygenator, it was reported that a fiber leak occurred, as device had a leak from the bottom of the oxy.5ml of blood was lost as a result of leak, but no blood transfusion was required.The same leak did not appear in multiple packs.See attached photo.The device was used to complete the procedure.There was no adverse patient effect associated with this event.There were 3 lots of fusion oxygenator used in the manufacture of this custom tubing pack, lots: 232832193, 232833326, 232597259.
|
| |
|
Additional Manufacturer Narrative
|
|
Device evaluation: visual inspection shows evidence of a fiber leak with blood staining on the bottom of the fiber bundle.Pressure integrity testing was performed at 3 l/pm with 23 psi, (1189 mmhg) of back pressure for 10 minutes.During the pressure integrity testing there were no leaks observed from the device including the fiber bundle.Conclusion: reason for the return was visually confirmed by the blood staining on the bottom of the fiber bundle and the photo provided by the customer.D.4.Serial number updated medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Search Alerts/Recalls
|